Data / Form D filings / RenBio, Inc.
RenBio, Inc.: Form D filings
RenBio, Inc., a biotechnology company in Long Island City, NY, filed 2 Form D notices with the SEC between 2021 and 2024. The latest, on September 6, 2024, reports $5.3 million sold of a $6 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 30-02 48th Avenue, Long Island City, NY, 11101
- Phone
- (646) 440-9411
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1840723
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | New notice | $6,000,000 | $5,250,000 | $750,000 | 7 | Aug 22, 2024 | sec.gov |
| Jan 19, 2021 | New notice | $24,000,000 | $14,000,000 | $10,000,000 | 7 | Dec 30, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jaap A. Goudsmit, M.D., Ph.D. | Director | |
| Rachel A. Liberatore, Ph.D. | Director, Executive Officer | |
| Zhi A. Hong, Ph.D. | Director | |
| Donald A. Tang | Director | |
| Annelyn A. O'Rourke | Executive Officer | |
| Walter A. Wang, Sr. | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Sep 2, 2024 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RenBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.